1 Min Read
March 21 (Reuters) - Cellectar Biosciences Inc:
* Cellectar Biosciences - United States patent and trademark office has granted a method of use patent for CLR 124, company’s cancer imaging agent Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.